The antitumor potential of M1-like TAMs is based on the lysis of tumor cells after phagocytosis or on the secretion of immunostimulatory cytokines and chemokines (e.g., IL-6, IL-12, TNF) which induce inflammation and thus tumor suppression [201]. This evidence concerns the gene IL6 and neoplasm.